JPM
JPMorgan Chase & Co.
JPM has the edge over NECB overall, supported by stronger fundamentals and stronger modeled upside.
NECB
Northeast Community Bancorp, Inc.
NECB's outlook is improving, though it still trails on the overall score.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
NECB Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| N/A | |
| N/A |
NECB's profitability is currently healthy, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like NECB.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM has the edge over NECB in the historical PE scenario, which offers more potential upside but is not a forecast.
NECB PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6.1x | $18.52 | -36% |
| Forward | 7.4x | $29.07 | — |
| Fair | 7.5x | $22.77 | -22% |
| Current | 9.6x | $29.07 | — |
| Expensive | 13x | $39.16 | +35% |
Historical ranges are pointers, not guarantees.
NECB's PE is in its expensive range at 9.6x. If earnings grow as analysts expect, today's price would be 7.4x next year's earnings, in its fair range.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
NECB Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| High |
NECB has the edge over JPM on the outlook, with more favorable valuation expectations.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM has the edge over NECB on earnings, with more consistent year-over-year improvement.
NECB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.94 | +30% |
| Q3 2026 | $3.03 | -5.6% |
| Q2 2026 | $3.11 | -5.5% |
| Q1 2026 | $3.21 | -6.7% |
| Q4 2025 | $3.25 | -7.7% |
| Q3 2025 | $3.21 | -15% |
| Q2 2025 | $3.29 | -9.4% |
| Q1 2025 | $3.44 | +0.9% |
| Q4 2024 | $3.52 | +6% |
NECB earned $3.03 per share over the past year, down 5.6% from the year before.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM has the edge over NECB on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM's operating margin was 40% last quarter, about level with the same quarter a year ago.
NECB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $26.1M | -3.2% |
| Q2 2026 | $25.3M | -2.5% |
| Q1 2026 | $24.9M | -2.2% |
| Q4 2025 | $26.4M | +3.9% |
| Q3 2025 | $27M | -2.5% |
| Q2 2025 | $25.9M | -3.8% |
| Q1 2025 | $25.5M | -0.2% |
| Q4 2024 | $25.4M | -4.3% |
NECB's revenue grew through 2023 and has held roughly level since: $26M last quarter, down 3.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 58% | -3.5 points |
| Q2 2026 | 55% | -4.9 points |
| Q1 2026 | 56% | -1.1 points |
| Q4 2025 | 59% | +2 points |
| Q3 2025 | 62% | -2 points |
| Q2 2025 | 59% | -6.1 points |
| Q1 2025 | 57% | -5.3 points |
| Q4 2024 | 57% | -7.5 points |
NECB has the edge over JPM on profitability, with a higher operating margin.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
NECB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $11M | -19% |
| Q2 2026 | $12.7M | -15% |
| Q1 2026 | $10.3M | -2.1% |
| Q4 2025 | $11.8M | +17% |
| Q3 2025 | $13.6M | -4.5% |
| Q2 2025 | $14.9M | +35% |
| Q1 2025 | $10.6M | -18% |
| Q4 2024 | $10.1M | -14% |
NECB has the edge over JPM on cash generation, producing positive trailing cash flow while its opponent burns cash.
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over NECB on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
NECB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +28K shares |
| 1 year | -0.5% | -66K shares |
| 3 years | -8.5% | -1.3M shares |
| 5 years | -17% | -2.8M shares |
NECB has 14M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $168,000 |
| Q2 2026 | $1.1M |
| Q1 2026 | $3.6M |
| Q4 2025 | $1.4M |
| Q4 2024 | $726,000 |
| Q3 2024 | — |
| Q2 2024 | $1.2M |
| Q1 2024 | $1.3M |
NECB spent $6M buying back its own shares over the past year.
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM has the edge over NECB on leverage, with a lower net debt burden relative to earnings.
NECB Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 1.9x | Healthy |
| Q1 2026 | -0.9x | Net Cash |
| Q4 2025 | -0.2x | Net Cash |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.2x | Healthy |
| Q1 2025 | -1.4x | Net Cash |
| Q3 2024 | -1.3x | Net Cash |
| Q2 2024 | -1.0x | Net Cash |
NECB's net debt is about 1.9 years of its operating earnings (EBITDA), up from 1.2 years a year ago. Net leverage isn't a meaningful measure for financial services companies like NECB.
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
NECB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 69.8 | Neutral |
| Stochastic | 76.8 | Neutral |
NECB's weekly RSI is 70 (neutral) and its Stochastic is 77 (neutral).
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM is trading at 14x earnings, a 10% premium to the Financial Services sector's median of 13x.
NECB PE vs Financial Services Sector
| Metric | NECB | Sector median | Relative |
|---|---|---|---|
| PE | 9.6x | 13x | 26% below |
| PE % | 69 | 63 | 6 pts above |
NECB has the edge over JPM on valuation relative to its sector.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM's trend is mixed: it's above four of its five weekly moving averages, and 45% above its 200-week average.
NECB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.9 | 4.4% above |
| 20 week MA | $27.2 | 6.8% above |
| 50 week MA | $25.3 | 15% above |
| 100 week MA | $23.9 | 22% above |
| 200 week MA | $20.8 | 40% above |
NECB has the edge over JPM on trend strength, trading above more of its moving averages.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has finished higher in four of the last six years. It's up 4.5% so far in 2026.
NECB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $8.80 | $10.3 | +17% |
| 2021 | $10.3 | $11.2 | +8.8% |
| 2022 | $11.2 | $15.0 | +35% |
| 2023 | $15.0 | $17.7 | +18% |
| 2024 | $17.7 | $24.8 | +40% |
| 2025 | $24.8 | $23.0 | -7.3% |
| 2026 YTD | $23.0 | $29.1 | +27% |
NECB has the edge over JPM on returns for 2026, with the stronger performance.